Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Glucocorticoid Use for Rheumatoid Arthritis Still Sparks Debate

Anand N. Malaviya, MD, FRCP, Master-ACR  |  June 15, 2015

Glucocorticoids: The Debate Continues Déjà vu … In past decades, rheumatologists have seen, heard, practiced and taught much of what has been argued in the “ongoing debate” on the use of glucocorticoids (GCs) in the management of rheumatoid arthritis (RA).1 It is heartening to note that eminent professors have stuck to their premise all these…

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:Drugsglucocorticoidpatient careRheumatoid arthritisSafetyTreatment

Data Collection Drives Evaluation of Psoriasis Treatments

Michele B. Kaufman, PharmD, BCGP  |  June 10, 2015

For six years, the Psoriasis Longitudinal Assessment and Registry (PSOLAR) has collected data to assess the infection risk for drugs treating systemic psoriasis.

Filed under:Biologics/DMARDsDrug Updates Tagged with:adverse drug reactionBiologicsPsoriasisPsoriasis Longitudinal Assessment and Registry

Rheumatologist Recalls Personal Experience with RA

Monica Piecyk, MD  |  May 15, 2015

In late March 2012, I awoke with pain in my left hand. I had difficulty moving my metacarpophalangeal (MCP) joints. They did not move smoothly, but clunked. As I repeatedly attempted to open and close my hand, I realized that I had morning stiffness. As the pain and stiffness gradually improved over the next hour,…

Filed under:ConditionsOpinionPatient PerspectivePractice SupportProfilesRheumatoid ArthritisSpeak Out Rheum Tagged with:DiagnosisManagementPhysician–PatientRheumatoid arthritisrheumatologistSpeak Out Rheumatology

Figures 1 & 2: On exam, the patient had thickening of the skin on her extremities.

Dermatology Symptoms Point to Connective Tissue Disorder

Natalie A. Wright, MD, and Joseph F. Merola, MD, MMSc, FAAD, FACR  |  May 15, 2015

The Case A 68-year-old woman with a past medical history of Charcot-Marie-Tooth presents with thickening of the skin on her trunk and extremities, which she has had for the past seven months (see Figures 1 and 2). Her symptoms first began with swelling of her bilateral upper and lower extremities. She is now having difficulty…

Filed under:ConditionsSystemic Sclerosis Tagged with:connective tissue disorderDermatologyeosinophilic fasciitis

Letters: Biomarkers for Rheumatoid Arthritis

Ronald van Vollenhoven, MD, PhD  |  May 15, 2015

Biomarkers for RA I read the article, “Finding Biomarkers in RA Remains Elusive Goal” (February 2015 The Rheumatologist), with great interest. The author correctly identifies the multi-biomarker disease activity assay (MBDA; Vectra DA) as a potential biomarker that identifies RA patients at risk for radiographic progression. The author names a study presented at the 2014…

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersRheumatoid arthritisviewpoint

Plaquenil: From Malaria Treatment to Managing Lupus, RA

Charles Radis, DO  |  May 15, 2015

In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…

Filed under:ConditionsDrug UpdatesRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:drugLupusPlaquenilRheumatoid arthritis

Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Jennifer Stichman, MD, and Dennis J. Boyle, MD  |  April 1, 2015

Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:adherenceBoyleMedicationpatient carerheumatology

Advice Rheumatologists Can Share with Patients Planning to Relocate, a Patient Perspective

Sarah Troxell, RN, BSN  |  April 1, 2015

Tips for stocking up on medications, providing comprehensive health history to new physicians and coping with stress

Filed under:ConditionsRheumatoid Arthritis Tagged with:Medicationpatient carerheumatologyStressTroxell

Coding Corner Question: March

From the College  |  March 2, 2015

Coding for chemotherapy infusion with a drug reaction

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingchemotherapyCodingInfusionrheumatology

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Filed under:Drug Updates Tagged with:Certolizumab PegolclazakizumabdrugFDAhydrocodone bitartrateKaufmanrheumatologySafety

  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences